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ABSTRACT
Signet-ring cell carcinoma (SRCC) of the ampulla of Vater is a very rare case and only 28 cases have beed 
reported in the English literature. Herein, we report a 59-year-old woman with SRCC of the ampulla of Vater. 
She developed symptoms of obstructive jaundice at early stage of disease and underwent pylorus-preserving 
Whipple procedure as definitive treatment. Histopathology examination showed numerous tumor cells with 
intracytoplasmic mucin and eccentric nuclei. Her tumor has already invaded the serosa of duodenum, but no 
infiltration to the stomach, pancreas, and lymphovascular structure. Her surgical margins and regional lymph 
nodes were free of tumor. She was diagnosed with T2N0M0 (stage IB) SRCC of the ampulla of Vater. No adjuvant 
treatment was given and she has been doing well for five months after surgery.
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ABSTRAK
Signet-ring cell carcinoma (SRCC) ampulla Vater merupakan kasus yang sangat jarang dan baru 28 kasus 
yang dilaporkan dalam literatur berbahasa Inggris. Kami melaporkan kasus seorang wanita berusia 59 tahun 
dengan SRCC ampulla Vater stadium awal yang memberikan gejala ikterus obstruktif dan menjalani prosedur 
Whipple dengan tetap mempertahankan pilorus. Pemeriksaan histopatologi menunjukkan adanya sebukan sel 
tumor dengan musin intrasitoplasmik dan nukleus eksentrik, serta invasi tumor pada lapisan serosa duodenum, 
namun tidak ditemukan adanya infiltrasi ke lambung, pankreas, dan jaringan limfovaskuler. Tepi sayatan dan 
kelenjar getah bening regional bebas dari sel tumor sehingga disimpulkan bahwa pasien ini menderita SRCC 
stadium IB (T2N0M0). Pasien tidak diberikan terapi ajuvan dan kondisinya masih baik hingga lima bulan 
pasca operasi.
Kata kunci: Signet ring cell carcinoma, ampulla Vater, prosedur Whipple dengan mempertahankan pylorus
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INTRODUCTION
Carcinomas of the papilla of Vater represent 
the second largest proportion of periampullary 
carcinomas, which include ampullary carcinoma and 
carcinomas of the pancreas, the distal bile duct, and 
the periampullary duodenum.1 Most patients manifest 
symptoms early in the course of their disease due to 
biliary obstruction. Therefore, their resection rate at 
diagnosis is considerably high, i.e. 62-96%.2
The pathogenesis of carcinomas of the ampulla 
of Vater is special. The ampulla of Vater is a valve 
organ which includes the border between two 
different types of mucosa. The intestinal mucosa 
of the ampulloduodenum adjoins the mucosa of 
the ampullo-pancreatico-biliary duct (the common 
channel).3 This area is exposed to three different kind 
of juices, i.e. pancreatic juice, bile, and gastric juice 
and three different epithelial types can be found here. 
Therefore, this area has the potency to transform into 
malignancy. Most ampullary carcinomas are usually 
well-differentiated adenocarcinomas. Signet-ring cell 
carcinoma (SRCC) of the ampulla of Vater is very rare 
and no specific guidelines about their management are 
available.4,5
 Here, we present a case of SRCC of the ampulla 
of Vater, which is successfully managed with pylorus-
preserving pancreaticoduodenectomy (Whipple 
procedure).
Case Report
A 59-year-old woman was referred to our hospital 
for further management of her obstructive jaundice. 
She had a five-month-long history of nausea and three-
month-long history of jaundice. Magnetic resonance 
imaging (MRI) and magnetic resonance cholangio 
pancreatography (MRCP) revealed dilated common 
bile duct, common hepatic duct, and intrahepatic duct, 
with enlargement of the gall bladder and hepatomegaly, 
but without any visible mass lesion (Figure 1). 
Gastroduodenoscopy showed moderate-to-severe 
duodenitis at the bulbar part. Histopathologic sample 
from duodenum showed a small part of gland had 
changed into tumor mass, which might mimic signet 
ring cell carcinoma.
She was referred to our hospital for further 
management. On physical examination, she looked 
icteric without other remarkable findings. Laboratory 
examination showed decreased haemoglobin level 
(9.8 g/dL), increased white blood cells count (12800/
µL), increased platelet count (881000/µL), increased 
carbohydrate antigen (CA) 19-9 level (68.72 U/
mL), and increased total bilirubin 11.07 mg/dL with 
predominant direct bilirubin 9.8 mg/dL. Endoscopic 
retrograde cholangiopancreatography (ERCP) showed 
a swollen ampulla with erosive and erythematous 
mucosa along the duodenal bulb to the second part 
of duodenum (Figure 2A). Biliary cannulation was 
difficult to perform so we placed a percutaneous 
transhepatic biliary drainage (PTBD) tube using a 22-G 
Chiba needle and a 6-French dilator to gain access 
to the common bile duct. A 0.035-inch hydrophilic 
guide-wire was advanced through the stenosis into the 
duodenum, which was then exchanged for a 0.035-
inch stiff guide-wire. Finally, an 8.5-French drainage 
catheter was inserted alongside the guidewire into the 
narrow segment. The outer part of the drainage catheter 
was connected to a urine bag so the bile could flow to 
the duodenum and to the drainage bag. Percutaneous 
transhepatic cholangiogram showed dilated common 
bile duct, common hepatic duct, intrahepatic ducts, 
and enlarged gall bladder (Figure 2B). One month 
later, the patient underwent a pylorus-preserving 
pancreaticoduodenectomy (Whipple procedure) and 
Figure 1. Magnetic resonance imaging (MRI) (Figure 1A) and 
magnetic resonance cholangio-pancreatography (MRCP) 
(Figure 1B) showed dilatation of common bile duct, common 
hepatic duct, and intrahepatic duct, with enlargement of gall 
bladder, but without dilatation of pancreatic duct. No visible 
mass lesion could be determined in these pictures.
Figure 2A. Endoscopic retrograde cholangiopancreatography 
(ERCP) showed a swollen ampulla with a reddish and erosive 
mucosa. 2B. Percutaneous transhepatic cholangiogram, 
performed during placement of percutaneous transhepatic 
biliary drainage (PTBD) catheter, showed dilated common bile 
duct, common hepatic duct, intrahepatic ducts, and enlarged 
gall bladder.
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she has been doing well five months after surgery.
Pathological Findings
The resection specimen showed a 2.5 x 1.5 x 2 cm 
thickening area of duodenum around the orifice of 
the ampulla of Vater. Histologically, the thickening 
part contained simple columnar epithelial cells with 
hyperplastic goblet cells and diffusely distributed 
signet-ring cells containing intracytoplasmic mucin 
with eccentric nuclei (Figure 3A). The tumor infiltrated 
the duodenal serosa (Figure 3B), but the pancreas, 
stomach (Figure 3D), and surgical margins were free of 
tumor. No lymphovascular invasion was present within 
the tumor. Of the nine common bile duct lymph nodes, 
none was positive for metastatic tumor cells (Figure 
3C). According to American Joint Committee on 
Cancer TNM classification, this patient was diagnosed 
as T2N0M0 (stage 1B).6 The patient was not given 
share identical morphology despite different primary 
site of origin, therefore in unknown primary cases, 
immunohistochemical profiling may help in the workup.
According to Wen et al, SRCC of the ampulla 
of Vater may be categorized into four subtypes: 
intestinal-type, pancreaticobiliary-type, gastric, 
and mixed types (composed of intestinal mucosa 
lining and pancreaticobiliary epithelium).8 This 
classification is based on immunohistochemistry 
methods, using cytokeratin (CK) and mucin (MUC) 
immunohistochemical staining. Patients with intestinal-
type ampullary SRC had a better prognosis compared 
with the pancreatobiliary type. Furthermore, gastric 
differentiation in ampullary SRC of intestinal type or 
pancreatobiliary type, demonstrated worse prognosis 
than others. Coexpression of the E-cadherin/β-catenin 
complex is also a marker of poor prognosis. The 
findings of Wen et al give highlights to the origin of 
SRCC of the ampulla of Vater. In 1982, Blundell et 
al hypothesized that SRCC arose from the presence 
of gastric metaplasia in the ampulla of Vater. Using 
immunohistochemical staining with antibodies to 
cytokeratins and mucins, Zhou et al also proposed 
that SRCC were histogenetically related to intestinal 
mucosa.8,10,11
Confirming a diagnosis of ampullary neoplasms 
can be challenging. Patients may present with 
obstructive jaundice without any evidence of mass 
lesion in abdominal CT scan or endoscopy. Serum 
CA 19-9 is elevated in 86.4% of ampullary carcinoma 
patients.12 Endoscopic ultrasound may help to find 
mass lesion obstructing the biliary system. During 
the diagnostic workup, it is difficult to distinguish 
between primary ampullary carcinoma and the more 
common periampullary tumors, such as pancreatic, 
duodenum, and bile duct carcinomas. To complicate 
further, there are no specific guidelines for diagnosis of 
ampullary neoplasms. Usually, ampullary neoplasms 
are incorporated into the guidelines of biliary tract or 
pancreatic carcinomas.13 From a surgical point of view, 
the distinction is not essential because if a malignant 
lesion is suspected in that area, the patients will undergo 
the same procedure (pancreaticoduodenectomy 
or Whipple procedure). However, ampullary and 
periampullary tumors have different prognosis.
There is no specific guideline regarding treatment 
of ampullary carcinoma. Due to their location, the size 
of ampullary carcinomas is often small at the time 
of diagnosis and tumor resection is the mainstay of 
treatment.14 Predictors of survival in ampullary SRCC 
have not been elaborated due to the small number 
Figure 3A. Signet-ring tumor cells showed intracytoplasmic 
mucin that displaces nucleus to one side (yellow arrow signs) B. 
Tumor cells (green arrow) infiltrated the duodenal serosa (black 
arrow), but no tumor cells were found in the pancreas. C. None 
of the regional lymph nodes was positive for tumor cells. D. 
No tumor cells were found in the gastric mucosa (blue arrow).
adjuvant treatment and remained well during three-
month follow up.
DISCUSSION
Signet-ring cell carcinoma (SRCC) usually occurs 
in the gastrointestinal tract, especially in the stomach, 
and SRCC of the ampulla of Vater is extremely rare. In 
a tertiary hospital in China, of all 162 patients treated 
with ampullary carcinomas over five-year period, only 
eight cases (4.9%) were identified as SRCC.7,8 Signet-
ring cell carcinoma is characterized by the presence of 
typical signet-ring cells, i.e. cells that contain mucins 
that displace the nucleus to one side.9 When this 
morphologic change presents in more than 50% of tumor 
cells, it is defined as SRCC.9 Signet-ring cell carcinomas 
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of cases. Signet ring cell carcinoma of the stomach 
carries a poor prognosis, with five-year survival rate 
only 16.2%. In contrary, based on previously reported 
cases, the follow-up period of resected patients 
with SRCC of the ampulla of Vater varied from 6 
to 134 months.4 The worst follow-up period was in 
patients with primary tumor invading pancreas (T3) 
or peripancreatic tissue (T4), regional lymph node 
metastasis, or distant metastasis.4,5,8,15,16,17 In patients 
with periampullary adenocarcinoma, pancreatobiliary 
type differentiation, regional lymph node involvement, 
and vessel involvement are independent adverse 
predictors of survival.18 Our patient was diagnosed as 
T2N0M0 (stage IB) so we did not plan to give adjuvant 
treatment, such as chemotherapy or radiotherapy, and 
she still performed well five months after surgery. Pre-
operative biliary drainage with PTBD was performed 
in our patient approximately one month before surgery 
to manage her symptoms of jaundice and improve her 
quality of life while waiting for surgery.
CONCLUSION
We presented a very rare case of SRCC of 
the ampulla of Vater, with invasion to the wall of 
duodenum. No specific treatment guidelines are 
available. Although several cases have been reported 
previously, the prognosis after resection in early stage 
cancer is not clear.
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